Impact of Enterobacteriaceae bacteremia on survival in patients with hepatorenal failure.
Impact of Enterobacteriaceae bacteremia on survival in patients with hepatorenal failure.
Saudi J Kidney Dis Transpl. 2018 Nov-Dec;29(6):1311-1319
Authors: Soliman AR, Ahmed RM, Abdalla A, Soliman M, Saeed M
Abstract
Enterobacteriaceae are now the predominant pathogens isolated in patients with liver cell failure associated with bloodstream infections. We conducted a retrospective cohort study of patients who were admitted for the diagnosis of hepatorenal failure (HRF) between June 1999 and May 2008 to investigate the risk factors of Enterobacteriaceae bacteremia (EB). EB was defined as the isolation of an EB species from at least one blood culture within three months following diagnosis of HRF. Variables were collected from the medical records and analyzed in relation to EB. Twenty-four (32.5%) of the 73 patients developed EB. The origin of EB was abdominal in 21% of the patients, urinary in 12.5%, pulmonary in 16.5%, and primary in the remaining patients (50%). Two-thirds of EB occurred within 10 days following the development of HRF. The main pathogens were Escherichia coli (44%), Enterobacter species (20%) and Klebsiella pneumoniae (22%). Eighteen patients (75%) with EB died. Variables significantly associated with EB after multivariate analysis were a model for end-stage liver disease score >20 [odds ratio (OR): 2.84, P <0.02], posthepatitis B liver cirrhosis (OR: 4.72, P <0.05), posthepatitis C liver cirrhosis (OR: 3.4...
Source: Saudi Journal of Kidney Diseases and Transplantation - Category: Urology & Nephrology Authors: Soliman AR, Ahmed RM, Abdalla A, Soliman M, Saeed M Tags: Saudi J Kidney Dis Transpl Source Type: research
More News: Cirrhosis | Gastroenteritis | Intensive Care | Kidney Transplant | Kidney Transplantation | Liver | Liver Disease | Liver Transplant | Middle East Health | Saudi Arabia Health | Study | Transplants | Urology & Nephrology